Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1194325

ACLIDINIUM
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1

Basic Information

ChEMBL ID CHEMBL1194325
Name ACLIDINIUM
Phase Approved
Structure Type MOL
InChI Key ASMXXROZKSBQIH-VITNCHFBSA-N
Therapeutic ✓ Yes

Known Names

Aclidinium Aclidinium cation Aclidinium ion
1
Targets
3
Activities
1
Assay Types
3
PK Parameters
6
Publications
3
Known Names
1
Indications

Molecular Properties

484.7
MW (Da)
4.67
ALogP
6
HBA
1
HBD
55.8
PSA (Ų)
0.27
QED
0
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2012
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Topical

Flags

Natural Product
USAN Stem -clidinium; -ium
USAN Year 2007

Extended Properties

Molecular Formula C26H30NO4S2+
MW 484.66
Aromatic Rings 3
Heavy Atoms 33
NP-Likeness -0.04

Indications

Pulmonary Disease, Chronic Obstructive

Activity Summary

IC50 3 meas. best 8.36

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Muscarinic acetylcholine receptor M3
CHEMBL245
IC50 8.36 8.36 4.4 2

Pharmacokinetic Data

Parameter Value Units Species
CL 64.0 uL.min-1.(10^6cells)-1 Homo sapiens
CL 79.99 uL.min-1.(10^6cells)-1 Rattus norvegicus
CL 140.0 mL.min-1.g-1 Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3301361 ADMET 3
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL3301361 No relevant target 1
22961681 10.1124/dmd.112.047068 Bile salt export pump 1
- 10.1101/2020.04.21.054387 SARS-CoV-2 1
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 1

Data from ChEMBL 36 via Core Engine